Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4′-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry

Authors

  • Britt Jansson,

    Corresponding author
    1. Division of Pharmacokinetics and Drug Therapy, Department of Biopharmaceutical Sciences, Box 591, SE-751 24 Uppsala, Sweden
    • Division of Pharmacokinetics and Drug Therapy, Department of Biopharmaceutical Sciences, Box 591, SE-751 24 Uppsala, Sweden.
    Search for more papers by this author
  • Doaa Elsherbiny,

    1. Division of Pharmacokinetics and Drug Therapy, Department of Biopharmaceutical Sciences, Box 591, SE-751 24 Uppsala, Sweden
    Search for more papers by this author
  • Ulrika S. H. Simonsson

    1. Division of Pharmacokinetics and Drug Therapy, Department of Biopharmaceutical Sciences, Box 591, SE-751 24 Uppsala, Sweden
    Search for more papers by this author

Rapid Commun. Mass Spectrom. 2006; 20: 463–472.

Due to an error during production, Fig. 1(c) should appear as follows:

Figure 1.

Ancillary